ELOXX PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 1.47 million shares for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-10.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2018-08-10
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2017-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2017-03-31 was 436.36K shares.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2016-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2016-09-30 was 0.00 shares.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2017 was 436.36K shares, a 10.15% decline from fiscal 2016.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2016 was 485.68K shares, a 59.65% decline from fiscal 2015.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2015 was 1.20M shares, a 54.62% increase from fiscal 2014.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2014 was 778.48K shares, a 768.16% increase from fiscal 2013.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month as first filed |
|---|---|---|---|---|---|
| 2018-06-30 | 1.47M shares 10-Q · filed 2018-08-10 | ||||
| 2017-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | 436.36K shares derived: sum of 2 quarters · filed 2017-10-13 | 436.36K shares derived: sum of 3 quarters · filed 2017-10-13 | 436.36K shares 10-K · filed 2017-10-13 | |
| 2017-03-31 | 436.36K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-22 | 436.36K shares derived: sum of 2 quarters · filed 2017-05-22 | 436.36K shares 10-Q · filed 2017-05-22 | 767.04K shares derived: sum of 4 quarters · filed 2017-10-13 | |
| 2016-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-10 | 0.00 shares 10-Q · filed 2017-02-10 | 330.68K shares derived: sum of 3 quarters · filed 2017-10-13 | 330.68K shares derived: sum of 4 quarters · filed 2017-10-13 | |
| 2016-09-30 | 0.00 shares 10-Q · filed 2016-11-14 | 330.68K shares derived: sum of 2 quarters · filed 2017-10-13 | 330.68K shares derived: sum of 3 quarters · filed 2017-10-13 | 485.68K shares derived: sum of 4 quarters · filed 2017-10-13 | |
| 2016-06-30 | 330.68K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | 330.68K shares derived: sum of 2 quarters · filed 2017-10-13 | 485.68K shares derived: sum of 3 quarters · filed 2017-10-13 | 485.68K shares 10-K · filed 2017-10-13 | |
| 2016-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-12 | 155.00K shares derived: sum of 2 quarters · filed 2016-05-12 | 155.00K shares 10-Q · filed 2016-05-12 | 166.34K shares derived: sum of 4 quarters · filed 2017-10-13 | |
| 2015-12-31 | 155.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-16 | 155.00K shares 10-Q · filed 2016-02-16 | 166.34K shares derived: sum of 3 quarters · filed 2017-10-13 | 693.19K shares derived: sum of 4 quarters · filed 2017-10-13 | |
| 2015-09-30 | 0.00 shares 10-Q · filed 2015-11-16 | 11.34K shares derived: sum of 2 quarters · filed 2017-10-13 | 538.19K shares derived: sum of 3 quarters · filed 2017-10-13 | 1.20M shares derived: sum of 4 quarters · filed 2017-10-13 | |
| 2015-06-30 | 11.34K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | 538.19K shares derived: sum of 2 quarters · filed 2017-10-13 | 1.20M shares derived: sum of 3 quarters · filed 2017-10-13 | 1.20M shares 10-K · filed 2017-10-13 | |
| 2015-03-31 | 526.85K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-14 | 1.19M shares derived: sum of 2 quarters · filed 2015-05-14 | 1.19M shares 10-Q · filed 2015-05-14 | 1.90M shares derived: sum of 4 quarters · filed 2016-10-13 | |
| 2014-12-31 | 665.48K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-17 | 665.48K shares 10-Q · filed 2015-02-17 | 1.37M shares derived: sum of 3 quarters · filed 2016-10-13 | 1.37M shares derived: sum of 4 quarters · filed 2016-10-13 | |
| 2014-09-30 | 0.00 shares 10-Q · filed 2014-11-14 | 704.40K shares derived: sum of 2 quarters · filed 2016-10-13 | 704.40K shares derived: sum of 3 quarters · filed 2016-10-13 | 705.20K shares derived: sum of 4 quarters · filed 2016-10-13 | |
| 2014-06-30 | 704.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-10-13 | 704.40K shares derived: sum of 2 quarters · filed 2016-10-13 | 705.20K shares derived: sum of 3 quarters · filed 2016-10-13 | 778.48K shares 10-K · filed 2016-10-13 | |
| 2014-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-09 | 800.00 shares derived: sum of 2 quarters · filed 2014-05-09 | 74.08K shares 10-Q · filed 2014-05-09 | -7.19M shares derived: sum of 4 quarters · filed 2015-10-09 | |
| 2013-12-31 | 800.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14 | 74.08K shares 10-Q · filed 2014-02-14 | -7.19M shares derived: sum of 3 quarters · filed 2015-10-09 | -6.54M shares derived: sum of 4 quarters · filed 2015-10-09 | |
| 2013-09-30 | 73.28K shares 10-Q · filed 2013-11-14 | -7.19M shares derived: sum of 2 quarters · filed 2015-10-09 | -6.54M shares derived: sum of 3 quarters · filed 2015-10-09 | 162.95K shares derived: sum of 4 quarters · filed 2015-10-09 | |
| 2013-06-30 | -7.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-09 | -6.61M shares derived: sum of 2 quarters · filed 2015-10-09 | 89.67K shares derived: sum of 3 quarters · filed 2015-10-09 | 89.67K shares 10-K · filed 2015-10-09 | 8.97M shares 10-K · filed 2013-09-11 |
| 2013-03-31 | 655.30K shares 10-Q · filed 2013-05-15 | 7.36M shares derived: sum of 2 quarters · filed 2013-05-15 | 7.36M shares 10-Q · filed 2013-05-15 | ||
| 2012-12-31 | 6.70M shares 10-Q · filed 2013-02-14 | 6.70M shares 10-Q · filed 2013-02-14 | |||
| 2012-06-30 | -5.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-29 | -4.81M shares derived: sum of 2 quarters · filed 2014-09-29 | -4.16M shares derived: sum of 3 quarters · filed 2014-09-29 | 52.74K shares 10-K · filed 2014-09-29 | 5.27M shares 10-K/A · filed 2012-10-26 |
| 2012-03-31 | 204.17K shares 10-Q · filed 2013-05-15 | 851.67K shares derived: sum of 2 quarters · filed 2013-05-15 | 5.06M shares 10-Q · filed 2013-05-15 | ||
| 2011-12-31 | 647.50K shares 10-Q · filed 2013-02-14 | 4.86M shares 10-Q · filed 2013-02-14 | |||
| 2011-09-30 | 4.21M shares 10-Q · filed 2012-11-14 | ||||
| 2011-06-30 | 4.58M shares 10-K · filed 2013-09-11 | ||||
| 2010-06-30 | 2.95M shares 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |